Merck KGaA's stock remains a 'hold' due to its high valuation, trading at an earnings multiple of around 20 and a 4.5% free ...

Merck & Co. Inc. closed 29.59% below its 52-week high of $134.63, which the company reached on June 25th.

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas ...

Investors in Merck & Co Inc (Symbol: MRK) saw new options begin trading today, for the April 11th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRK ...

Merck shares have been under pressure amid disappointing sales trends for its Gardasil HPV vaccine. The company's broader drug portfolio continues to perform well and is driving a strong earnings ...

propelling the micro-cap biotech stock into the top 10 trending symbols on Stocktwits. The company is set to receive a $15 million milestone payment from Merck, triggered by the latter's ...

At Holdings Channel, we have reviewed the latest batch of the 27 most recent 13F filings for the 12/31/2024 reporting period, and noticed that Merck & Co Inc (Symbol: MRK) was held by 15 of these ...

Merck (MRK) announced results from the Phase 3 KEYNOTE-966 trial investigating KEYTRUDA, Merck’s anti-PD-1 therapy, in combination ...